Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.

导出 OA

翻译打印收藏纠错

作者： Guangqi,Li ^[1] ; Yuanjun,Jiang ^[2] ; Xintong,Lyu ^[1] ; Yiru,Cai ^[1] ; Miao,Zhang ^[1] ; Guang,Li ^[1] ; Qiao,Qiao ^[1]

作者单位： Department of Radiation Oncology, the First Hospital of China Medical University, Shenyang, China. ^[1] Department of Urology, the First Hospital of China Medical University, Shenyang, China. ^[2]

关键词 TCGA chemosensitivity immunotherapy patient stratification radiosensitivity risk model transcriptome

主题词成年人(Adult);综合疗法(Combined Modality Therapy);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);神经胶质瘤(Glioma);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤蛋白质类(Neoplasm Proteins);预后(Prognosis);存活率分析(Survival Analysis);肿瘤微环境(Tumor Microenvironment)

DOI 10.1111/jcmm.15145

PMID 32160398

发布时间 2021-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

Journal of cellular and molecular medicine

2020年24卷8期

4726-4735页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.

Journal of cellular and molecular medicine

相似文献

Journal of cellular and molecular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.

Journal of cellular and molecular medicine

相似文献

Journal of cellular and molecular medicine

相关期刊

检索历史清除